EP3273995
COMBINED USE OF ALGINATE OLIGOMERS AND THE CFTR MODULATOR LUMACAFTOR IN THE TREATMENT OF CONDITIONS ASSOCIATED WITH CFTR DYSFUNCTION
:
EP einkaleyfi: Þýðing ekki lögð inn:
23.3.2016:
14.7.2021:
16711320.8
:
22.3.2036
:
COMBINED USE OF ALGINATE OLIGOMERS AND THE CFTR MODULATOR LUMACAFTOR IN THE TREATMENT OF CONDITIONS ASSOCIATED WITH CFTR DYSFUNCTION
23.3.2016
14.7.2021
:
ALGIPHARMA AS:
Industriveien 33, 1337 Sandvika, NO
:
DESSEN, Arne:
3440 Røyken, NO
:
MYRSET, Astrid Hilde:
0873 Oslo, NO
:
RYE, Philip:
1359 Eiksmarka, NO
:
201504878:
23.3.2015:
GB
:
EP2016056458:
23.3.2016
:
A61K 31/443, A61K 31/405, A61K 31/4164, A61K 31/4245, A61K 31/43, A61K 31/47, A61K 31/496, A61K 31/4965, A61K 31/7036, A61K 31/734, A61K 45/06, A61P 11/00